The Carlyle Group Inc.
As of Oct 22, 2026, Carlyle Group is in Stage 4, the downtrend phase, now in week 4 (since Sep 29, 2026). It closed at $39.20, 39.5% below its 52-week high and below its 200-day average, which is falling.
The Carlyle Group Inc. is an investment firm specializing in direct and fund of fund investments. More about the company
Pro read
ProOur read
Setup score
Momentum
Edge
Is CG early, or has it already run? Pro answers that for every US stock we cover, after every close.
Renews monthly until you cancel. Cancel any time in Plan & billing.
CG among Asset Management103rd of 140 by relative strength
All 140 →| # | Stock | Stage | RS | 1M |
|---|---|---|---|---|
| 1 | CYPH | Stage 2 · wk 7 | 99 | −17.5% |
| 2 | AMTD | Stage 2 · wk 1 | 99 | +4011.1% |
| 3 | MGLD | Stage 2 · wk 4 | 94 | +105.2% |
| 4 | AAMI | Stage 2 · wk 41 | 94 | +1.4% |
| 5 | ASST | Stage 2 · wk 7 | 92 | +0.1% |
| 6 | AMG | Stage 2 · wk 21 | 91 | +8.0% |
| 7 | WT | Stage 2 · wk 39 | 91 | −10.6% |
| 8 | VCTR | Stage 2 · wk 39 | 91 | +1.0% |
| …103 | CG | Stage 4 · wk 4 | 33 | −1.8% |
Carlyle Group: quick answers
What stage is Carlyle Group in?
As of Oct 22, 2026, Carlyle Group (CG) is in Stage 4, the downtrend phase. It entered Stage 4 on Sep 29, 2026 and is in week 4. What the four stages mean
Is Carlyle Group in an uptrend?
No. Carlyle Group is in a Stage 4 downtrend. It trades 17.4% below its 200-day average, which is falling.
How far is Carlyle Group from its 52-week high?
Carlyle Group closed at $39.20 on Oct 22, 2026, 39.5% below its 52-week high of $64.75. Its 52-week low is $35.77.
How has Carlyle Group performed over the past year?
As of Oct 22, 2026, Carlyle Group is down 30.6% over the past year and down 34.2% so far in 2026.
Which sector and industry is Carlyle Group in?
Carlyle Group is in the Asset Management industry, part of the Financials sector.
About this companyFinancials· Asset Management
The Carlyle Group Inc. is an investment firm specializing in direct and fund of fund investments. Within direct investments, it specializes in management-led/ Leveraged buyouts, privatizations, divestitures, strategic minority equity investments, structured credit, global distressed and corporate opportunities, small and middle market, equity private placements, consolidations and buildups, senior debt, mezzanine and leveraged finance, and venture and growth capital financings, seed/startup, early venture, emerging growth, turnaround, mid venture, late venture, PIPES, recapitalization. The firm invests across four segments which include Corporate Private Equity, Real Assets, Global Market Strategies, and Solutions. The firm typically invests in industrial, agribusiness, ecological sector, fintech, airports, parking, Plastics, Rubber, diversified natural resources, minerals, farming, aerospace, defense, automotive, consumer, retail, industrial, infrastructure, energy, power, healthcare, software, software enabled services, semiconductors, communications infrastructure, financial technology, utilities, gaming, systems and related supply chain, electronic systems, systems, oil and gas, processing facilities, power generation assets, technology, systems, real estate, financial services, transportation, business services, telecommunications, media, and logistics sectors. Within the industrial sector, the firm invests in manufacturing, building products, packaging, chemicals, metals and mining, forestry and paper products, and industrial consumables and services. In consumer and retail sectors, it invests in food and beverage, retail, restaurants, consumer products, domestic consumption, consumer services, personal care products, direct marketing, and education. Within aerospace, defense, business services, and government services sectors, it seeks to invest in defense electronics, manufacturing and services, government contracting and services, information technology, distribution companies, supply chains, aftermarket services, cybersecurity and digital resilience, digital transformation. Within healthcare, biotech and medtech innovation, life sciences, healthcare IT, pharmacy, pharma commercialization. In telecommunication and media sectors, it invests in cable TV, directories, publishing, entertainment and content delivery services, wireless infrastructure/services, fixed line networks, satellite services, broadband and Internet, and infrastructure. Within real estate, the firm invests in office, hotel, industrial, retail, for sale residential, student housing, hospitality, multifamily residential, homebuilding and building products, and senior living sectors. The firm seeks to make investments in growing business including those with overleveraged balance sheets. The firm seeks to hold its investments for four to six years. In the healthcare sector, it invests in healthcare services, outsourcing services, companies running clinical trials for pharmaceutical companies, managed care, pharmaceuticals, pharmaceutical related services, healthcare IT, medical, products, and devices. It seeks to invest in companies based in Sub-Saharan focusing on Ghana, Kenya, Mozambique, Botswana, Nigeria, Uganda, West Africa, North Africa and South Africa focusing on Tanzania and Zambia; Asia focusing on Pakistan, India, Hong Kong, South East Asia, Indonesia, Philippines, Malaysia, Singapore, Vietnam, Taiwan, Korea, and Japan; Australia; New Zealand; Europe focusing on France, Italy, Denmark, United Kingdom, Germany, Austria, Belgium, Finland, Iceland, Ireland, Netherlands, Norway, Portugal, Spain, Benelux , Sweden, Switzerland, Hungary, Poland, and Russia; Middle East focusing on Bahrain, Jordan, Kuwait, Lebanon, Oman, Qatar, Saudi Arabia, Turkey, and UAE; North America focusing on United States which further invest in Southeastern United States, Texas, Boston, San Francisco Bay Area and Pacific Northwest; Asia Pacific; Soviet Union, Central-Eastern Europe, and Israel; Nordic region; and South America focusing on Mexico, Argentina, Brazil, Chile, and Peru. The firm seeks to invest in food, financial, and healthcare industries in Western China. In the real estate sector, the firm seeks to invest in various locations across Europe focusing on France and Central Europe, United States, Asia focusing on China, and Latin America. It typically invests between $2.24 million and $50 million for venture investments and between $50 million and $2 billion for buyouts in companies with enterprise value of between $31.57 million and $1000 million and sales value of $50 million and $300 million. It seeks to invest in companies with market capitalization greater than $50 million and EBITDA between $5 million to $25 million. It prefers to take a majority or a minority stake. While investing in Japan, it does not invest in companies with more than 1,000 employees and prefers companies' worth between $100 million and $150 million. The firm originates, structures, and acts as lead equity investor in the transactions. The Carlyle Group Inc. was founded in 1987 and is based in Washington, District of Columbia with additional offices across North America, South America, Asia, Australia and Europe.
Visit company website →All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.